Skip to main content

Mitral Valve Replacement

  • Chapter
  • First Online:
  • 326 Accesses

Abstract

The etiology of mitral valve disease is generally categorized as degenerative, ischemic, rheumatic, or infectious. Globally, rheumatic heart disease (RHD) remains a major cause of mitral valve disease. Mitral valve replacement may be performed for both mitral valve stenosis and mitral valve regurgitation due to structural or functional changes in the mitral valve apparatus. Replacement options include mechanical valves, bioprosthetic valves, and less commonly stentless valves or use of a pulmonary autograft. In general, mechanical valves offer increased durability compared to bioprosthetic valves but at the expense of an increased risk of valve thrombosis requiring long term coagulation. Transcatheter mitral valve replacement is an emerging technology for the management of mitral valve disease.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2017;70:252–89.

    Article  Google Scholar 

  2. Movahed MR, Ahmadi-Kashani M, Kasravi B, Saito Y. Increased prevalence of mitral stenosis in women. J Am Soc Echocardiogr. 2006;19:911–3.

    Article  Google Scholar 

  3. Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol. 2011;3:67–84.

    Article  Google Scholar 

  4. Iung B, Vahanian A. Epidemiology of acquired valvular heart disease. Can J Cardiol. 2014;30:962–70.

    Article  Google Scholar 

  5. Iung B, Baron G, Tornos P, Gohlke-Barwolf C, Butchart EG, Vahanian A. Valvular heart disease in the community: a European experience. Curr Probl Cardiol. 2007;32:609–61.

    Article  Google Scholar 

  6. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–11.

    Article  Google Scholar 

  7. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373:1382–94.

    Article  Google Scholar 

  8. Enriquez-Sarano M, Schaff HV, Orszulak TA, et al. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation. 1995;91:1022–8.

    Article  CAS  Google Scholar 

  9. Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370:23–32.

    Article  CAS  Google Scholar 

  10. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000;36:1152–8.

    Article  CAS  Google Scholar 

  11. D’Alessandro L, Narducci C, Pucci A, et al. The use of mechanical valves in the treatment of valvular heart disease. New York: Springer; 1986. p. 31.

    Google Scholar 

  12. Butterfield M, Fisher J, Davies GA, Spyt TJ. Comparative study of the hydrodynamic function of the CarboMedics valve. Ann Thorac Surg. 1991;52:815–20.

    Article  CAS  Google Scholar 

  13. David TE, Ivanov J, Armstrong S, Feindel CM, Cohen G. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg. 2001;121:268–77.

    Article  CAS  Google Scholar 

  14. Neville PH, Aupart MR, Diemont FF, Sirinelli AL, Lemoine EM, Marchand MA. Carpentier-Edwards pericardial bioprosthesis in aortic or mitral position: a 12-year experience. Ann Thorac Surg. 1998;66:143–7.

    Article  Google Scholar 

  15. Frater RW. Stentless mitral valves. J Thorac Cardiovasc Surg. 2007;133:861–4.

    Article  Google Scholar 

  16. Kabbani S, Jamil H, Nabhani F, Hamoud A, Katan K, Sabbagh N, et al. Analysis of 92 mitral pulmonary autograft replacement (Ross II) operations. J Thorac Cardiovasc Surg. 2007;134:902–8.

    Article  Google Scholar 

  17. LaPar DJ, Acker MA, Gelijns AC, Kron IL. Repair or replace for severe ischemic mitral regurgitation: prospective randomized multicenter data. Ann Cardiothorac Surg. 2015;4:411–6.

    PubMed  PubMed Central  Google Scholar 

  18. Chitwood WR Jr, Wixon CL, Elbeery JR, Moran JF, Chapman WH, Lust RM. Video-assisted minimally invasive mitral valve surgery. J Thorac Cardiovasc Surg. 1997;114:773–80.

    Article  Google Scholar 

  19. Hawkins RB, Mehaffey JH, Mullen MM, Nifong WL, Chitwood WR, Katz MR, et al., Investigators for the Virginia Cardiac Services Quality Initiative. A propensity matched analysis of robotic, minimally invasive, and conventional mitral valve surgery. Heart. 2018. https://doi.org/10.1136/heartjnl-2018-313129. pii: heartjnl-2018-313129. [Epub ahead of print].

    Article  Google Scholar 

  20. Sternik L, Zehr KJ, Orszulak TA, Mullany CJ, Daly RC, Schaff HV. The advantage of repair of mitral valve in acute endocarditis. J Heart Valve Dis. 2002;11:91–7.

    Google Scholar 

  21. Heras M, Chesebro JH, Fuster V, Penny WJ, Grill DE, Bailey KR, et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol. 1995;25:1111–9.

    Article  CAS  Google Scholar 

  22. Brennan JM, Edwards FH, Zhao Y, O'Brien S, Booth ME, Dokholyan RS, et al. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. J Am Coll Cardiol. 2012;60:971–7.

    Article  Google Scholar 

  23. Ezekowitz MD. Anticoagulation management of valve replacement patients. J Heart Valve Dis. 2002;11(Suppl 1):S56–61.

    PubMed  Google Scholar 

  24. Jegaden O, Eker A, Delahaye F, Montagna P, Ossette J, Durand de Gevigney G, et al. Thromboembolic risk and late survival after mitral valve replacement with the St Jude Medical valve. Ann Thorac Surg. 1994;58:1721–8.

    Article  CAS  Google Scholar 

  25. Bapat V, Rajagopal V, Meduri C, Farivar RS, Walton A, Duffy SJ, et al., Intrepid Global Pilot Study Investigators. Early experience with new transcatheter mitral valve replacement. J Am Coll Cardiol. 2018; 71:12–21.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Damien J. LaPar .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Blitzer, D., Song, J.J., LaPar, D.J. (2020). Mitral Valve Replacement. In: Raja, S. (eds) Cardiac Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-24174-2_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-24174-2_40

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-24173-5

  • Online ISBN: 978-3-030-24174-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics